644 filings
Page 23 of 33
8-K
2oi12abv6uof76
14 May 19
Entry into a Material Definitive Agreement
4:05pm
424B5
ibvqn030q7od
9 May 19
Prospectus supplement for primary offering
9:28am
8-K
3yp2jax j4ngfug7j9
7 May 19
Regulation FD Disclosure
1:03pm
UPLOAD
yc3erryiabrmvi
6 May 19
Letter from SEC
12:00am
4
hfkfvirjf7a81jad
29 Apr 19
AzurRx BioPharma / EDWARD BORKOWSKI ownership change
8:27pm
4
wcx6ju2k 29ije2b
29 Apr 19
AzurRx BioPharma / CHARLES J CASAMENTO ownership change
8:24pm
4
bdsrtxx
29 Apr 19
AzurRx BioPharma / Alastair Riddell ownership change
8:22pm
4
hwe haesjz
29 Apr 19
AzurRx BioPharma / Vern Lee Schramm ownership change
8:20pm
8-K
dca7uu2a
24 Apr 19
Other Events
3:15pm
8-K
14o6ikidu yy
11 Apr 19
Regulation FD Disclosure
9:50am
8-K
lirxsikxifzeumdcep
3 Apr 19
Entry into a Material Definitive Agreement
4:33pm
424B5
zgc18
2 Apr 19
Prospectus supplement for primary offering
8:56am
8-K
kqilmsg
28 Mar 19
Departure of Directors or Certain Officers
12:00am
D
qrwzhh9woizcx 267t0
1 Mar 19
$2M in debt / securities to be acquired, sold $2M, 1 investor
12:00am
SC 13D/A
qnv68fszls1yqco392kl
26 Feb 19
AzurRx BioPharma, Inc.
5:00pm
8-K
87flr t341rg
20 Feb 19
AzurRx BioPharma Announces First Patients Dosed in Phase II OPTION Clinical Trial
8:29am